30323741|t|Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma.
30323741|a|Glaucoma is a neurodegenerative disease that features progressive loss of retinal ganglion cells (RGCs). Increasing evidences have revealed that impaired mitochondrial dynamics occurs early in neurodegenerative diseases. Optic Atrophy Type 1 (OPA1), a mitochondrial fusion protein, has recently been suggested to be a mitophagic factor. Our previous studies found that glaucomatous retinal damage may be ameliorated by an increase in mitochondrial OPA1. In this study, we explored the mechanism involved in OPA1 mediated neuroprotection and its relationship with parkin dependent mitophagy in experimental glaucoma models. Our data showed that overexpression of OPA1 by viral vectors protected against RGC loss, attenuated Bax expression, and improved mitochondrial health and mitochondrial surface area. Parkin expression and the number of mitophagosomes were upregulated in OPA1 overexpressed RGCs under glutamate excitotoxicity. While knockdown of OPA1 by siRNA decreased protein expression of parkin in RGCs under glutamate excitotoxicity. Two weeks after intraocular pressure (IOP) elevation, the LC3-II/I ratio and the LAMP1 expression were increased in OPA1 overexpressed optic nerve. These findings suggest that OPA1 overexpression may protect RGCs by ways of enhancing mitochondria fusion and parkin mediated mitophagy. Interventions to promote mitochondrial fusion and mitophagy may provide a useful strategy to battle against glaucomatous RGC loss.
30323741	18	38	Optic Atrophy Type 1	Gene	4976
30323741	87	93	Parkin	Gene	5071
30323741	121	129	Glaucoma	Disease	MESH:D005901
30323741	131	139	Glaucoma	Disease	MESH:D005901
30323741	145	170	neurodegenerative disease	Disease	MESH:D019636
30323741	324	350	neurodegenerative diseases	Disease	MESH:D019636
30323741	352	372	Optic Atrophy Type 1	Gene	4976
30323741	374	378	OPA1	Gene	4976
30323741	500	527	glaucomatous retinal damage	Disease	MESH:D012164
30323741	579	583	OPA1	Gene	4976
30323741	638	642	OPA1	Gene	4976
30323741	694	700	parkin	Gene	5071
30323741	737	745	glaucoma	Disease	MESH:D005901
30323741	793	797	OPA1	Gene	4976
30323741	833	841	RGC loss	Disease	MESH:D016388
30323741	854	857	Bax	Gene	581
30323741	936	942	Parkin	Gene	5071
30323741	1007	1011	OPA1	Gene	4976
30323741	1037	1046	glutamate	Chemical	MESH:D018698
30323741	1047	1061	excitotoxicity	Disease	
30323741	1082	1086	OPA1	Gene	4976
30323741	1128	1134	parkin	Gene	5071
30323741	1149	1158	glutamate	Chemical	MESH:D018698
30323741	1159	1173	excitotoxicity	Disease	
30323741	1233	1236	LC3	Gene	84557
30323741	1256	1261	LAMP1	Gene	3916
30323741	1291	1295	OPA1	Gene	4976
30323741	1351	1355	OPA1	Gene	4976
30323741	1433	1439	parkin	Gene	5071
30323741	1568	1580	glaucomatous	Disease	
30323741	1581	1589	RGC loss	Disease	MESH:D016388
30323741	Association	MESH:D012164	4976
30323741	Association	MESH:D018698	4976
30323741	Negative_Correlation	MESH:D016388	4976
30323741	Negative_Correlation	4976	581
30323741	Positive_Correlation	4976	5071
30323741	Association	MESH:D005901	4976
30323741	Positive_Correlation	3916	4976
30323741	Positive_Correlation	4976	84557
30323741	Association	MESH:D005901	5071

